Please assess the completion status of the following clinical trial:

Trial Title: A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Histologically documented uterine papillary serous carcinoma (UPSC) with no visible residual disease.~2. Surgical staging to include total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal washings, and lymph node samplings.~3. Age \> 18 years.~4. ECOG performance status of \< 2.~5. Written voluntary informed consent.~Exclusion Criteria:~1. Patient has impairment of hepatic, renal or hematologic function as defined by the following baseline laboratory values:~   1. Serum SGOT and /or SGPT \> 2.5 times the institutional upper limit of normal~  2. Total serum bilirubin \> 1.5 mg/dl~  3. History of chronic or active hepatitis~  4. Serum creatinine \> 2.0 mg/dl~  5. Platelets \< 100,000/mm3~  6. Absolute neutrophil count (ANC) \< 1500/mm3~  7. Hemoglobin \< 8.0 g/dl (the patient may be transfused prior to study entry)~2. Patient has severe or uncontrolled concurrent medical disease (eg. uncontrolled diabetes, unstable angina, myocardial infarction within 6 months, congestive heart failure, etc.)~3. Patient has been treated with myelosuppressive chemotherapy within three weeks prior to study entry.~4. Patient with any prior chemotherapy or radiotherapy for pelvic malignancy.~5. Patients with dementia or altered mental status that would prohibit the giving and understanding of informed consent at the time of study entry.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Drug:Carboplatin and Paclitaxel and Radiation: Pelvic Radiation Therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).